FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005936675> ?p ?o ?g. }

• W3005936675 endingPage "1149" @default.
• W3005936675 startingPage "1144" @default.
• W3005936675 abstract "Increased comorbidities and a perceived high-bleeding risk often prevent the use of dual antiplatelet therapy (DAPT) in female patients. However, more aggressive antiplatelet treatment would certainly offer additional outcome benefits in coronary artery disease, especially among diabetic patients. The aim of the present study was to evaluate the gender differences in high-residual on treatment platelet reactivity (HRPR) among diabetic patients treated with DAPT. Our population is represented by a consecutive cohort of diabetic patients treated with DAPT (ASA + clopidogrel, ticagrelor or dose-adjusted prasugrel) for an acute coronary syndrome or elective PCI, undergoing platelet reactivity assessment at 30–90 days post-discharge. Aggregation was assessed by multiple-electrode aggregometry and in diabetic patients naïve to antiplatelet therapy, by light transmission aggregometry, surface expression of P-selectin and plasma concentration of Thromboxane B2. We included 472 patients, 113 (23.9%) women. Female gender was associated with more advanced age, and increased comorbidities. Mean platelet reactivity did not differ according to gender. The rate of HRPR was similar in women as compared to men (for ASA: adjusted OR[95%CI] = 0.59[0.27–1.33], p = 0.21, for ADP-antagonists: adjusted OR[95%CI] = 1.24[0.25–1.80], p = 0.27), however, the benefits of the new ADP-antagonists on platelet reactivity were lower in women than in men (p interaction = 0.01). No impact of gender on platelet reactivity was confirmed among 50 diabetic patients naïve to antiplatelet therapy. Among diabetic patients receiving dual antiplatelet therapy gender does not affect platelet reactivity or high-on treatment platelet reactivity. However, the enhanced platelet inhibition provided by the new-ADP antagonists of new-ADP antagonists could be mitigated in women." @default.
• W3005936675 created "2020-02-24" @default.
• W3005936675 creator A5014301894 @default.
• W3005936675 creator A5014715322 @default.
• W3005936675 creator A5015479782 @default.
• W3005936675 creator A5036024315 @default.
• W3005936675 creator A5037008118 @default.
• W3005936675 creator A5047328504 @default.
• W3005936675 creator A5058341072 @default.
• W3005936675 creator A5067778460 @default.
• W3005936675 creator A5068649190 @default.
• W3005936675 creator A5073420948 @default.
• W3005936675 creator A5091586877 @default.
• W3005936675 date "2020-09-01" @default.
• W3005936675 modified "2023-09-30" @default.
• W3005936675 title "Gender Differences in Platelet Reactivity in Diabetic Patients Receiving Dual Antiplatelet Therapy" @default.
• W3005936675 cites W1516015099 @default.
• W3005936675 cites W1686859449 @default.
• W3005936675 cites W1815204764 @default.
• W3005936675 cites W1891516986 @default.
• W3005936675 cites W1927574886 @default.
• W3005936675 cites W1977317212 @default.
• W3005936675 cites W1980162439 @default.
• W3005936675 cites W1987914702 @default.
• W3005936675 cites W1990018236 @default.
• W3005936675 cites W1990144565 @default.
• W3005936675 cites W1992742717 @default.
• W3005936675 cites W2007462808 @default.
• W3005936675 cites W2010831619 @default.
• W3005936675 cites W2020099275 @default.
• W3005936675 cites W2024622456 @default.
• W3005936675 cites W2025039880 @default.
• W3005936675 cites W2029236332 @default.
• W3005936675 cites W2032167693 @default.
• W3005936675 cites W2040823835 @default.
• W3005936675 cites W2063658366 @default.
• W3005936675 cites W2079743286 @default.
• W3005936675 cites W2088103865 @default.
• W3005936675 cites W2093125083 @default.
• W3005936675 cites W2093392020 @default.
• W3005936675 cites W2099022345 @default.
• W3005936675 cites W2108257482 @default.
• W3005936675 cites W2138058610 @default.
• W3005936675 cites W2142360591 @default.
• W3005936675 cites W2146607562 @default.
• W3005936675 cites W2158221812 @default.
• W3005936675 cites W2159819836 @default.
• W3005936675 cites W2161887684 @default.
• W3005936675 cites W2166722207 @default.
• W3005936675 cites W2171792003 @default.
• W3005936675 cites W2202434074 @default.
• W3005936675 cites W2273498793 @default.
• W3005936675 cites W2293477021 @default.
• W3005936675 cites W2316112497 @default.
• W3005936675 cites W2330846286 @default.
• W3005936675 cites W2342318753 @default.
• W3005936675 cites W2345294515 @default.
• W3005936675 cites W2589085334 @default.
• W3005936675 cites W2751347423 @default.
• W3005936675 cites W2752033985 @default.
• W3005936675 cites W47455383 @default.
• W3005936675 doi "https://doi.org/10.1016/j.carrev.2020.02.007" @default.
• W3005936675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32085942" @default.
• W3005936675 hasPublicationYear "2020" @default.
• W3005936675 type Work @default.
• W3005936675 sameAs 3005936675 @default.
• W3005936675 citedByCount "5" @default.
• W3005936675 countsByYear W30059366752020 @default.
• W3005936675 countsByYear W30059366752022 @default.
• W3005936675 countsByYear W30059366752023 @default.
• W3005936675 crossrefType "journal-article" @default.
• W3005936675 hasAuthorship W3005936675A5014301894 @default.
• W3005936675 hasAuthorship W3005936675A5014715322 @default.
• W3005936675 hasAuthorship W3005936675A5015479782 @default.
• W3005936675 hasAuthorship W3005936675A5036024315 @default.
• W3005936675 hasAuthorship W3005936675A5037008118 @default.
• W3005936675 hasAuthorship W3005936675A5047328504 @default.
• W3005936675 hasAuthorship W3005936675A5058341072 @default.
• W3005936675 hasAuthorship W3005936675A5067778460 @default.
• W3005936675 hasAuthorship W3005936675A5068649190 @default.
• W3005936675 hasAuthorship W3005936675A5073420948 @default.
• W3005936675 hasAuthorship W3005936675A5091586877 @default.
• W3005936675 hasConcept C126322002 @default.
• W3005936675 hasConcept C134018914 @default.
• W3005936675 hasConcept C164705383 @default.
• W3005936675 hasConcept C2777028646 @default.
• W3005936675 hasConcept C2777628954 @default.
• W3005936675 hasConcept C2777698277 @default.
• W3005936675 hasConcept C2777849778 @default.
• W3005936675 hasConcept C2778213512 @default.
• W3005936675 hasConcept C2780890252 @default.
• W3005936675 hasConcept C2909112448 @default.
• W3005936675 hasConcept C49059817 @default.
• W3005936675 hasConcept C500558357 @default.
• W3005936675 hasConcept C555293320 @default.
• W3005936675 hasConcept C71924100 @default.
• W3005936675 hasConcept C89560881 @default.
• W3005936675 hasConceptScore W3005936675C126322002 @default.

• next